探索影响 COVID-19 严重程度的因素:一项匹配病例对照研究。

IF 3.3 4区 医学 Q1 Medicine
G H Mansouri, F Darjiyani, F Karami Robati, L Allahqoli, H Mirzaei, H Salehiniya, I Alkatout
{"title":"探索影响 COVID-19 严重程度的因素:一项匹配病例对照研究。","authors":"G H Mansouri, F Darjiyani, F Karami Robati, L Allahqoli, H Mirzaei, H Salehiniya, I Alkatout","doi":"10.26355/eurrev_202411_36914","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>COVID-19, first identified in December 2019, quickly became a global pandemic and remains a significant public health concern. Robust data is rare, especially in pregnant women. The symptoms of this disease range from mild to severe respiratory distress syndrome and mortality. The present study aimed to evaluate the factors influencing COVID-19 severity in women to be better prepared in case of a new epidemic.</p><p><strong>Patients and methods: </strong>This retrospective matched case-control study based on body mass index, smoke, and drug use was conducted on all women hospitalized with COVID-19 at Afzalipour Hospital in Kerman, Iran from the beginning of 2020 to 2021. In this study, 130 female patients with COVID-19 were included, with 65 patients in the case group (moderate and severe cases of COVID-19) and 65 patients in the control group (mild cases of COVID-19). The data were entered into the Stata software, and to determine the effective risk factors for the severity of COVID-19 disease, both univariate and multivariable conditional logistic regression analyses were utilized, assuming individual matching. Finally, the odds ratios (OR), along with 95% confidence intervals (CI), were estimated.</p><p><strong>Results: </strong>The average age of women in the case group was 36.92 ± 7.07 years, compared to 30.12 ± 6.27 years in the control group. Among all patients, 50% were pregnant, with a mean gestational age of 30.03 weeks. Significant factors affecting disease severity included age, education, employment status, place of residence, insurance coverage, comorbidities, and pregnancy status. The highest adjusted odds ratio for severe COVID-19 was associated with comorbidities (OR = 7.8, 95% CI: 2.3-11.1), while the lowest was associated with urban residence (OR = 2.8, 95% CI: 1.02-4.5). Overall, significant predictors of severe COVID-19 included age over 30, urban residence, lack of insurance, a short duration between diagnosis and hospitalization, comorbidities, and non-pregnancy.</p><p><strong>Conclusions: </strong>The study identified several significant predictors of severe COVID-19 among women, including age over 30, urban residency, lack of insurance coverage, presence of comorbidities, and non-pregnancy, all of which were associated with a heightened risk of severe illness. Notably, comorbidities emerged as the strongest predictor. These findings underscore the critical need for targeted interventions to protect vulnerable populations.</p>","PeriodicalId":12152,"journal":{"name":"European review for medical and pharmacological sciences","volume":"28 21","pages":"4553-4560"},"PeriodicalIF":3.3000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Exploring factors influencing COVID-19 severity: a matched case-control study.\",\"authors\":\"G H Mansouri, F Darjiyani, F Karami Robati, L Allahqoli, H Mirzaei, H Salehiniya, I Alkatout\",\"doi\":\"10.26355/eurrev_202411_36914\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>COVID-19, first identified in December 2019, quickly became a global pandemic and remains a significant public health concern. Robust data is rare, especially in pregnant women. The symptoms of this disease range from mild to severe respiratory distress syndrome and mortality. The present study aimed to evaluate the factors influencing COVID-19 severity in women to be better prepared in case of a new epidemic.</p><p><strong>Patients and methods: </strong>This retrospective matched case-control study based on body mass index, smoke, and drug use was conducted on all women hospitalized with COVID-19 at Afzalipour Hospital in Kerman, Iran from the beginning of 2020 to 2021. In this study, 130 female patients with COVID-19 were included, with 65 patients in the case group (moderate and severe cases of COVID-19) and 65 patients in the control group (mild cases of COVID-19). The data were entered into the Stata software, and to determine the effective risk factors for the severity of COVID-19 disease, both univariate and multivariable conditional logistic regression analyses were utilized, assuming individual matching. Finally, the odds ratios (OR), along with 95% confidence intervals (CI), were estimated.</p><p><strong>Results: </strong>The average age of women in the case group was 36.92 ± 7.07 years, compared to 30.12 ± 6.27 years in the control group. Among all patients, 50% were pregnant, with a mean gestational age of 30.03 weeks. Significant factors affecting disease severity included age, education, employment status, place of residence, insurance coverage, comorbidities, and pregnancy status. The highest adjusted odds ratio for severe COVID-19 was associated with comorbidities (OR = 7.8, 95% CI: 2.3-11.1), while the lowest was associated with urban residence (OR = 2.8, 95% CI: 1.02-4.5). Overall, significant predictors of severe COVID-19 included age over 30, urban residence, lack of insurance, a short duration between diagnosis and hospitalization, comorbidities, and non-pregnancy.</p><p><strong>Conclusions: </strong>The study identified several significant predictors of severe COVID-19 among women, including age over 30, urban residency, lack of insurance coverage, presence of comorbidities, and non-pregnancy, all of which were associated with a heightened risk of severe illness. Notably, comorbidities emerged as the strongest predictor. These findings underscore the critical need for targeted interventions to protect vulnerable populations.</p>\",\"PeriodicalId\":12152,\"journal\":{\"name\":\"European review for medical and pharmacological sciences\",\"volume\":\"28 21\",\"pages\":\"4553-4560\"},\"PeriodicalIF\":3.3000,\"publicationDate\":\"2024-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European review for medical and pharmacological sciences\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.26355/eurrev_202411_36914\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European review for medical and pharmacological sciences","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.26355/eurrev_202411_36914","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

目的:COVID-19 于 2019 年 12 月首次发现,并迅速成为全球流行病,目前仍是一个重大的公共卫生问题。大量数据非常罕见,尤其是在孕妇中。这种疾病的症状从轻微到严重的呼吸窘迫综合征和死亡不等。本研究旨在评估影响女性 COVID-19 严重程度的因素,以便在发生新的流行病时做好更充分的准备:这项回顾性匹配病例对照研究以体重指数、吸烟和药物使用为基础,针对 2020 年初至 2021 年期间在伊朗克尔曼 Afzalipour 医院住院的所有 COVID-19 女性患者。本研究共纳入 130 名 COVID-19 女性患者,其中病例组(COVID-19 中度和重度病例)和对照组(COVID-19 轻度病例)各 65 名。将数据输入 Stata 软件,在假设个体匹配的情况下,利用单变量和多变量条件逻辑回归分析确定 COVID-19 疾病严重程度的有效风险因素。最后,估算出了几率比(OR)和 95% 的置信区间(CI):病例组妇女的平均年龄为(36.92 ± 7.07)岁,对照组妇女的平均年龄为(30.12 ± 6.27)岁。所有患者中有 50%为孕妇,平均孕周为 30.03 周。影响疾病严重程度的重要因素包括年龄、教育程度、就业状况、居住地、保险范围、合并症和妊娠状况。重度 COVID-19 的调整赔率最高与合并症有关(OR = 7.8,95% CI:2.3-11.1),最低与城市居住地有关(OR = 2.8,95% CI:1.02-4.5)。总体而言,严重 COVID-19 的重要预测因素包括年龄超过 30 岁、居住在城市、没有保险、诊断与住院时间间隔短、合并症和未怀孕:该研究发现了女性患重症 COVID-19 的几个重要预测因素,包括年龄超过 30 岁、居住在城市、缺乏保险、存在合并症和未怀孕,所有这些因素都与重症风险增加有关。值得注意的是,合并症是最强的预测因素。这些发现突出表明,亟需采取有针对性的干预措施来保护弱势群体。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Exploring factors influencing COVID-19 severity: a matched case-control study.

Objective: COVID-19, first identified in December 2019, quickly became a global pandemic and remains a significant public health concern. Robust data is rare, especially in pregnant women. The symptoms of this disease range from mild to severe respiratory distress syndrome and mortality. The present study aimed to evaluate the factors influencing COVID-19 severity in women to be better prepared in case of a new epidemic.

Patients and methods: This retrospective matched case-control study based on body mass index, smoke, and drug use was conducted on all women hospitalized with COVID-19 at Afzalipour Hospital in Kerman, Iran from the beginning of 2020 to 2021. In this study, 130 female patients with COVID-19 were included, with 65 patients in the case group (moderate and severe cases of COVID-19) and 65 patients in the control group (mild cases of COVID-19). The data were entered into the Stata software, and to determine the effective risk factors for the severity of COVID-19 disease, both univariate and multivariable conditional logistic regression analyses were utilized, assuming individual matching. Finally, the odds ratios (OR), along with 95% confidence intervals (CI), were estimated.

Results: The average age of women in the case group was 36.92 ± 7.07 years, compared to 30.12 ± 6.27 years in the control group. Among all patients, 50% were pregnant, with a mean gestational age of 30.03 weeks. Significant factors affecting disease severity included age, education, employment status, place of residence, insurance coverage, comorbidities, and pregnancy status. The highest adjusted odds ratio for severe COVID-19 was associated with comorbidities (OR = 7.8, 95% CI: 2.3-11.1), while the lowest was associated with urban residence (OR = 2.8, 95% CI: 1.02-4.5). Overall, significant predictors of severe COVID-19 included age over 30, urban residence, lack of insurance, a short duration between diagnosis and hospitalization, comorbidities, and non-pregnancy.

Conclusions: The study identified several significant predictors of severe COVID-19 among women, including age over 30, urban residency, lack of insurance coverage, presence of comorbidities, and non-pregnancy, all of which were associated with a heightened risk of severe illness. Notably, comorbidities emerged as the strongest predictor. These findings underscore the critical need for targeted interventions to protect vulnerable populations.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
5.30
自引率
6.10%
发文量
906
审稿时长
2-4 weeks
期刊介绍: European Review for Medical and Pharmacological Sciences, a fortnightly journal, acts as an information exchange tool on several aspects of medical and pharmacological sciences. It publishes reviews, original articles, and results from original research. The purposes of the Journal are to encourage interdisciplinary discussions and to contribute to the advancement of medicine. European Review for Medical and Pharmacological Sciences includes: -Editorials- Reviews- Original articles- Trials- Brief communications- Case reports (only if of particular interest and accompanied by a short review)
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信